Mineralys Therapeutics, Inc.
Pharmaceutical company · Radnor, Pennsylvania, United States · Nasdaq: MLYS
Mineralys Therapeutics, Inc. is a pharmaceutical company headquartered in Radnor, Pennsylvania, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker MLYS. It has reported private securities offerings to the US SEC, most recently $118 million sold in a notice filed in 2022.
Mineralys Therapeutics at a glance
What does Mineralys Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $118 million sold (2022).
Frequently asked questions about Mineralys Therapeutics
Where is Mineralys Therapeutics headquartered?
Mineralys Therapeutics, Inc. is headquartered in Radnor, Pennsylvania, United States.
What does Mineralys Therapeutics do?
Mineralys Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Mineralys Therapeutics a public company?
Yes. Mineralys Therapeutics, Inc. trades on Nasdaq under the ticker MLYS.
When was Mineralys Therapeutics founded?
The earliest incorporation on record for Mineralys Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.